Serial Mass Screening for Tuberculosis among Incarcerated Persons in Brazil.

Tuberculosis incarceration mass screening

Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
07 Feb 2024
Historique:
received: 26 05 2023
revised: 13 10 2023
accepted: 01 02 2024
medline: 7 2 2024
pubmed: 7 2 2024
entrez: 7 2 2024
Statut: aheadofprint

Résumé

Active search for tuberculosis cases through mass screening is widely described as a tool to improve case detection in hyperendemic settings. However, its effectiveness in high-risk populations, such as incarcerated people, is debated. Between 2017 and 2021, three rounds of mass screening were carried out in three Brazilian prisons. Social and health questionnaires, chest X-rays and Xpert MTB/RIF were performed. Over 80% of the prison population was screened. Overall, 684 cases of pulmonary tuberculosis were diagnosed. Prevalence across screening rounds was not statistically different. Among incarcerated persons with symptoms, the overall prevalence of tuberculosis per 100,000 persons was 8,497 (95% CI, 7,346-9,811), 11,115 (95% CI, 9,471-13,082), and 7,957 (95% CI, 6,380-9,882) in screening rounds one, two and three, respectively. Similar to our overall results, there were no statistical differences between screening rounds and within individual prisons. We found no statistical differences in CAD4TB scores across screening rounds among people with tuberculosis - the median scores in rounds 1, 2, and 3 were 82 (IQR, 63-97), 77 (IQR, 60-94), and 81 (IQR, 67-92), respectively. In this environment with hyperendemic rates of tuberculosis, three rounds of mass screening did not reduce the overall tuberculosis burden. In prisons, where a substantial amount of TB is undiagnosed annually, a range of complementary interventions and more frequent TB screening may be required.

Sections du résumé

BACKGROUND BACKGROUND
Active search for tuberculosis cases through mass screening is widely described as a tool to improve case detection in hyperendemic settings. However, its effectiveness in high-risk populations, such as incarcerated people, is debated.
METHODS METHODS
Between 2017 and 2021, three rounds of mass screening were carried out in three Brazilian prisons. Social and health questionnaires, chest X-rays and Xpert MTB/RIF were performed.
RESULTS RESULTS
Over 80% of the prison population was screened. Overall, 684 cases of pulmonary tuberculosis were diagnosed. Prevalence across screening rounds was not statistically different. Among incarcerated persons with symptoms, the overall prevalence of tuberculosis per 100,000 persons was 8,497 (95% CI, 7,346-9,811), 11,115 (95% CI, 9,471-13,082), and 7,957 (95% CI, 6,380-9,882) in screening rounds one, two and three, respectively. Similar to our overall results, there were no statistical differences between screening rounds and within individual prisons. We found no statistical differences in CAD4TB scores across screening rounds among people with tuberculosis - the median scores in rounds 1, 2, and 3 were 82 (IQR, 63-97), 77 (IQR, 60-94), and 81 (IQR, 67-92), respectively.
CONCLUSIONS CONCLUSIONS
In this environment with hyperendemic rates of tuberculosis, three rounds of mass screening did not reduce the overall tuberculosis burden. In prisons, where a substantial amount of TB is undiagnosed annually, a range of complementary interventions and more frequent TB screening may be required.

Identifiants

pubmed: 38324908
pii: 7603111
doi: 10.1093/cid/ciae055
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America.

Auteurs

Rafaele Carla Pivetta de Araujo (RC)

Health Sciences Research Laboratory, Federal University of Grande Dourados, Dourados, Brazil.

Leonardo Martinez (L)

Department of Epidemiology, School of Public Health, Boston University, Boston, Massachusetts, United States.

Andrea da Silva Santos (A)

Health Sciences Research Laboratory, Federal University of Grande Dourados, Dourados, Brazil.

Everton Ferreira Lemos (E)

School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil.

Roberto Dias de Oliveira (R)

Nursing Course, State University of Mato Grosso do Sul, Dourados, Brazil.
Graduate Program in Health Sciences, Federal University of Grande Dourados, Dourados, Brazil.

Mariana Croda (M)

School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil.

Dâmaris Porto Batestin Silva (DP)

School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil.

Isabella Beatriz Gonçalves Lemes (IBG)

School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil.

Eunice Atsuko Totumi Cunha (EAT)

Laboratory of Bacteriology, Central Laboratory of Mato Grosso do Sul, Campo Grande, Brazil.

Thais Oliveira Gonçalves (TO)

Laboratory of Bacteriology, Central Laboratory of Mato Grosso do Sul, Campo Grande, Brazil.

Paulo Cesar Pereira Dos Santos (PCP)

School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil.

Bruna Oliveira da Silva (BO)

Health Sciences Research Laboratory, Federal University of Grande Dourados, Dourados, Brazil.

Crhistinne Cm Gonçalves (CC)

School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil.

Jason R Andrews (JR)

Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, United States of America.

Julio Croda (J)

School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil.
Oswaldo Cruz Foundation, Campo Grande, MS, Brazil.
Department of Epidemiology of Microbial Diseases, Yale University School of Public Health, New Haven, CT, United States of America.

Classifications MeSH